logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12233110 B1

PDFFull Text
Date of Patent:
Feb. 25, 2025

Filed:

Feb. 16, 2024

Compositions comprising pharmaceutically acceptable salts of glucagon-like peptide-1 analogs and uses thereof

Applicant:

I20 Therapeutics, Inc., Cambridge, MA (US);

Inventors:

Tyler Brown, Cambridge, MA (US);

Kelly Ibsen, Boston, MA (US);

Assignee:

I20 THERAPEUTICS, INC., Cambridge, MA (US);

Attorney:

WILSON SONSINI GOODRICH & ROSATI

Primary Examiner:

Jeffrey E Russel

Int. Cl.
CPC ...
A61K 38/22 (2006.01); A61K 9/08 (2006.01); A61K 31/14 (2006.01); A61K 38/26 (2006.01); A61K 47/12 (2006.01); A61K 47/18 (2017.01); A61K 47/54 (2017.01); A61K 47/68 (2017.01); C07K 14/575 (2006.01); C07K 14/605 (2006.01); C07K 16/24 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
A61K 38/26 (2013.01); A61K 9/08 (2013.01); A61K 31/14 (2013.01); A61K 38/22 (2013.01); A61K 47/12 (2013.01); A61K 47/18 (2013.01); A61K 47/183 (2013.01); A61K 47/186 (2013.01); A61K 47/542 (2017.08); A61K 47/6845 (2017.08); C07K 14/575 (2013.01); C07K 14/605 (2013.01); C07K 16/241 (2013.01); A61K 38/00 (2013.01); C07K 2317/24 (2013.01);
Abstract

Provided herein are compounds having the structure of Formula I, wherein the compounds comprises a therapeutic agent having the sequence of SEQ ID NO: 35, and the compounds have an anion:cation molar ratio of from about 1:1 to about 1:7, and methods of using thereof for the treatment of metabolic diseases or disorders, including type 1 diabetes, type 2 diabetes, obesity, overweight, and nonalcoholic steatohepatitis, and for reducing weight in a subject in need thereof.

Find Patent Forward Citations

Brown, Tyler. (2025). Compositions comprising pharmaceutically acceptable salts of glucagon-like peptide-1 analogs and uses thereof (U.S. Patent No. 12233110). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12233110

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…